CN114366708A - 一种用于光电术后屏障修护的面膜及其制备方法 - Google Patents
一种用于光电术后屏障修护的面膜及其制备方法 Download PDFInfo
- Publication number
- CN114366708A CN114366708A CN202111575163.9A CN202111575163A CN114366708A CN 114366708 A CN114366708 A CN 114366708A CN 202111575163 A CN202111575163 A CN 202111575163A CN 114366708 A CN114366708 A CN 114366708A
- Authority
- CN
- China
- Prior art keywords
- phase
- mask
- lipid
- extract
- activator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004888 barrier function Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 150000002632 lipids Chemical class 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000012190 activator Substances 0.000 claims abstract description 30
- 230000008439 repair process Effects 0.000 claims abstract description 24
- 239000000047 product Substances 0.000 claims abstract description 22
- 102000010637 Aquaporins Human genes 0.000 claims abstract description 19
- 108010063290 Aquaporins Proteins 0.000 claims abstract description 19
- 239000013589 supplement Substances 0.000 claims abstract description 19
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 239000003974 emollient agent Substances 0.000 claims abstract description 11
- 239000006041 probiotic Substances 0.000 claims abstract description 11
- 230000000529 probiotic effect Effects 0.000 claims abstract description 11
- 235000018291 probiotics Nutrition 0.000 claims abstract description 11
- 239000002562 thickening agent Substances 0.000 claims abstract description 10
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- 230000008929 regeneration Effects 0.000 claims abstract description 8
- 238000011069 regeneration method Methods 0.000 claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 52
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 24
- 235000011187 glycerol Nutrition 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 22
- 235000019198 oils Nutrition 0.000 claims description 21
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 20
- 241000186660 Lactobacillus Species 0.000 claims description 19
- 238000000855 fermentation Methods 0.000 claims description 19
- 230000004151 fermentation Effects 0.000 claims description 19
- 229940039696 lactobacillus Drugs 0.000 claims description 19
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 18
- -1 glycerol glucoside Chemical class 0.000 claims description 18
- 229930182478 glucoside Natural products 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 14
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 13
- 235000012000 cholesterol Nutrition 0.000 claims description 13
- 235000020238 sunflower seed Nutrition 0.000 claims description 13
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 12
- 241000208152 Geranium Species 0.000 claims description 12
- 235000020221 chamomile extract Nutrition 0.000 claims description 12
- 229940119217 chamomile extract Drugs 0.000 claims description 12
- 229940101267 panthenol Drugs 0.000 claims description 12
- 235000020957 pantothenol Nutrition 0.000 claims description 12
- 239000011619 pantothenol Substances 0.000 claims description 12
- 229920002884 Laureth 4 Polymers 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 11
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 11
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims description 11
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 11
- 229940061515 laureth-4 Drugs 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 11
- 239000010452 phosphate Substances 0.000 claims description 11
- 229920002125 Sokalan® Polymers 0.000 claims description 10
- 239000007983 Tris buffer Substances 0.000 claims description 10
- 229960001631 carbomer Drugs 0.000 claims description 10
- 229960003966 nicotinamide Drugs 0.000 claims description 10
- 235000005152 nicotinamide Nutrition 0.000 claims description 10
- 239000011570 nicotinamide Substances 0.000 claims description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 10
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 claims description 9
- 229940119676 diethoxyethyl succinate Drugs 0.000 claims description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- 229960003237 betaine Drugs 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 8
- 230000001804 emulsifying effect Effects 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 8
- 238000007689 inspection Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 238000005070 sampling Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 7
- 235000013336 milk Nutrition 0.000 claims description 7
- 239000008267 milk Substances 0.000 claims description 7
- 210000004080 milk Anatomy 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 6
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 229940032094 squalane Drugs 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 241000207934 Eriodictyon Species 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- 240000004922 Vigna radiata Species 0.000 claims description 4
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 4
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 4
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 4
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 4
- 229940073490 sodium glutamate Drugs 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- 235000013322 soy milk Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 claims description 2
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940083987 anhydroxylitol Drugs 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 229940100485 methyl gluceth-10 Drugs 0.000 claims description 2
- 230000005693 optoelectronics Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 244000234609 Portulaca oleracea Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 10
- 230000008591 skin barrier function Effects 0.000 abstract description 6
- 208000035965 Postoperative Complications Diseases 0.000 abstract description 4
- 230000003796 beauty Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 15
- 241000219304 Portulacaceae Species 0.000 description 9
- 230000005622 photoelectricity Effects 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- CCLARULDIPFTCP-BOYHRMMASA-N (2r,3r,4r,5s)-heptane-1,2,3,4,5,6-hexol Chemical compound CC(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CCLARULDIPFTCP-BOYHRMMASA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 240000008632 Cota tinctoria Species 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 229960000281 trometamol Drugs 0.000 description 3
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 108090000991 Aquaporin 3 Proteins 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 229940069638 aloe vera leaf extract Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- 102000002579 Sphingosine N-acyltransferase Human genes 0.000 description 1
- 108020004714 Sphingosine N-acyltransferase Proteins 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及美容护肤领域,提供了一种用于光电术后屏障修护的面膜,还提供了上述面膜的制备方法。其用于光电术后屏障修护的面膜按质量百分比,包括:水分补充剂0.1‑8%、润肤剂0.1‑3%、乳化剂0.1‑1%、水通道蛋白激活剂2%、脂质补充剂0.1‑3%、敏感修护剂0.1‑3%、脂质再生激活剂0.1‑3%、益生菌激活剂0.1‑1%、增稠剂0.01‑0.5%、pH调节剂0.01‑0.1%,余量为水,以上组分的质量百分比之和为100%。本发明提供的面膜能够有效修护激光类项目对皮肤产生的副作用及对术后并发症的修复,能够有效补充生理脂质,修复皮肤屏障,恢复水通道蛋白的正常功能;经志愿者对屏障修复效果进行测试,结果显示,本发明产品能够明显改善光电术后皮肤的干燥、提高皮肤角质层水分、并保湿持久。
Description
技术领域
本发明涉及美容护肤领域,具体涉及一种用于光电术后屏障修护的面膜,还涉及上述面膜的制备方法。
背景技术
激光类项目可以将特定波长的激光光束透过表皮和真皮层,破坏色素细胞和色素颗粒,碎片经由体内的巨噬细胞处理吸收,安全不留疤痕,可高效的实现美白的目的,用适量的激光照射可以使皮肤变得细嫩、光滑。如治疗痤疮、黑痣、老年斑等。由于激光类项目无痛苦且安全可靠,受到人们欢迎。然而激光类项目同时也具有一些副作用,以及术后并发症,例如破坏皮脂膜、破坏水通道蛋白等。
破坏皮脂膜:激光的热和光化效应会影响糖基化神经酰胺合成酶的活性,影响神经酰胺的生成,皮肤易变得干燥、脱屑、敏感。激光还会破坏皮脂膜中的亚油酸、亚麻酸、脂质成分,降低皮肤屏障功能,降低皮肤抗炎能力,因此,激光术后容易感染。
破坏水通道蛋白:水通道蛋白存在于角质细胞的细胞膜上,负责转运是一种热敏感蛋白,激光的热度会破坏水通道蛋白的活性,导致表皮水分减少,皮肤变得干燥、脱屑、敏感。
由此,激光类医美项目术后需要补充生理脂质,修复皮肤屏障,恢复水通道蛋白的正常功能。
发明内容
基于上述背景,针对光电术后的并发症等问题,本发明的目的是提供一种用于光电术后屏障修护的面膜;本发明的另一目的是提供一种用于光电术后屏障修护的面膜的制备方法。
为实现以上目的,本发明采用以下的技术方案:
一种用于光电术后屏障修护的面膜,按质量百分比,包括:
水分补充剂0.1-8%、润肤剂0.1-3%、乳化剂0.1-1%、水通道蛋白激活剂2%、脂质补充剂0.1-3%、敏感修护剂0.1-3%、脂质再生激活剂0.1-3%、益生菌激活剂0.1-1%、增稠剂0.01-0.5%、pH调节剂0.01-0.1%,防腐剂0.1-1%,余量为水,以上组分的质量百分比之和为100%。
进一步地,所述脂质补充剂由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成。
上述技术方案中,如果脂质配比不合理,反而会减慢修复皮肤屏障的速度(可参见《药妆品》(第3版)58-60页),由此,本申请脂质补充剂由神经酰胺NP:胆固醇:向日葵籽油=2:4:1的黄金脂质配比构成。
进一步地,所述水通道蛋白激活剂为甘油葡糖苷、木糖醇葡糖苷、脱水木糖醇、木糖醇中的一种。
优选地,所述水通道蛋白激活剂为甘油葡糖苷。
上述技术方案中,采用甘油葡糖苷激活水通道蛋白AQP3。
进一步地,所述水分补充剂为甘油、丁二醇、1,2-戊二醇、1,2-己二醇、甘油聚醚-26、甜菜碱、甲基葡糖醇聚醚-10、透明质酸钠中的一种或多种。
优选地,所述水分补充剂为甘油、丁二醇、1,2-戊二醇、1,2-己二醇、甘油聚醚-26、甜菜碱。
进一步地,所述润肤剂为琥珀酸二乙氧基乙酯、辛酸/癸酸甘油三酯、角鲨烷、氢化聚异丁烯中的一种或多种。
优选地,所述润肤剂为琥珀酸二乙氧基乙酯。
进一步地,所述乳化剂为三(月桂醇聚醚-4)磷酸酯。
进一步地,所述敏感修护剂为泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物、库拉索芦荟叶提取物中的一种或多种。
优选地,所述敏感修护剂由泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物和库拉索芦荟叶提取物组成。
进一步地,所述脂质再生激活剂为烟酰胺。
进一步地,所述益生菌激活剂为乳酸杆菌/豆浆发酵产物滤液、乳酸杆菌/绿豆籽提取物/谷氨酸钠发酵产物滤液、乳酸杆菌/北美圣草发酵产物提取物中的一种。
优选地,所述益生菌激活剂为乳酸杆菌/豆浆发酵产物滤液。
进一步地,所述增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物中的一种。
优选地,所述增稠剂为卡波姆。
进一步地,所述pH调节剂为氢氧化钠、精氨酸、氨丁三醇中的一种。
优选地,所述pH调节剂为氢氧化钠。
进一步地,所述防腐剂为对羟基苯乙酮和/或己二醇。
一种用于光电术后屏障修护的面膜的制备方法,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,
A相:水、水分补充剂、增稠剂;
B相:脂质补充剂、乳化剂;
C相:pH调节剂、防腐剂、脂质再生激活剂;
D相:水通道蛋白激活剂、益生菌激活剂、敏感修护剂、润肤剂;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异,即得到本发明的面膜。
上述技术方案中,加入的pH调节剂,调节系统pH值为5.28-6.28。
进一步地,其中,
A相:水、甘油聚醚-26、甘油、甜菜碱、卡波姆;
B相:向日葵籽油、神经酰胺NP、胆固醇、三(月桂醇聚醚-4)磷酸酯;
C相:水、氢氧化钠、对羟基苯乙酮、己二醇、烟酰胺;
D相:甘油葡糖苷、乳酸杆菌/豆浆发酵产物滤液、泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物、库拉索芦荟叶提取物、琥珀酸二乙氧基乙酯。
本发明具有的有益效果是:
本发明提供的面膜能够有效修护激光类项目对皮肤产生的副作用及对术后并发症的修复,能够有效补充生理脂质,修复皮肤屏障,恢复水通道蛋白的正常功能;
本发明产品经志愿者对屏障修复效果进行测试,结果显示,本发明产品能够明显改善光电术后皮肤的干燥、提高皮肤角质层水分、并保湿持久。
具体实施方式
下面结合具体实施例对本发明进行详细的说明:
作为其中的一个实施例,一种用于光电术后屏障修护的面膜,按质量百分比,包括:
水分补充剂0.1-8%、润肤剂0.1-3%、乳化剂0.1-1%、水通道蛋白激活剂2%、脂质补充剂0.1-3%、敏感修护剂0.1-3%、脂质再生激活剂0.1-3%、益生菌激活剂0.1-1%、增稠剂0.01-0.5%、pH调节剂0.01-0.1%,防腐剂0.1-1%,余量为水,以上组分的质量百分比之和为100%。
作为其中的一个实施例,进一步地,所述脂质补充剂由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成。如果脂质配比不合理,反而会减慢修复皮肤屏障的速度(可参见《药妆品》(第3版)58-60页),由此,采用脂质补充剂由神经酰胺NP:胆固醇:向日葵籽油=2:4:1的黄金脂质配比构成。
作为其中的一个实施例,进一步地,所述水通道蛋白激活剂为甘油葡糖苷、木糖醇葡糖苷、脱水木糖醇、木糖醇中的一种。
作为其中的一个实施例,优选地,所述水通道蛋白激活剂为甘油葡糖苷。采用甘油葡糖苷激活水通道蛋白AQP3。
作为其中的一个实施例,进一步地,所述水分补充剂为甘油、丁二醇、1,2-戊二醇、1,2-己二醇、甘油聚醚-26、甜菜碱、甲基葡糖醇聚醚-10、透明质酸钠中的一种或多种。
作为其中的一个实施例,优选地,所述水分补充剂为甘油、丁二醇、1,2-戊二醇、1,2-己二醇、甘油聚醚-26、甜菜碱。
作为其中的一个实施例,进一步地,所述润肤剂为琥珀酸二乙氧基乙酯、辛酸/癸酸甘油三酯、角鲨烷、氢化聚异丁烯中的一种或多种。
作为其中的一个实施例,优选地,所述润肤剂为琥珀酸二乙氧基乙酯。
作为其中的一个实施例,进一步地,所述乳化剂为三(月桂醇聚醚-4)磷酸酯。
作为其中的一个实施例,进一步地,所述敏感修护剂为泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物、库拉索芦荟叶提取物中的一种或多种。
作为其中的一个实施例,优选地,所述敏感修护剂由泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物和库拉索芦荟叶提取物组成。
作为其中的一个实施例,进一步地,所述脂质再生激活剂为烟酰胺。
作为其中的一个实施例,进一步地,所述益生菌激活剂为乳酸杆菌/豆浆发酵产物滤液、乳酸杆菌/绿豆籽提取物/谷氨酸钠发酵产物滤液、乳酸杆菌/北美圣草发酵产物提取物中的一种。
作为其中的一个实施例,优选地,所述益生菌激活剂为乳酸杆菌/豆浆发酵产物滤液。
作为其中的一个实施例,进一步地,所述增稠剂为卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物中的一种。
作为其中的一个实施例,优选地,所述增稠剂为卡波姆。
作为其中的一个实施例,进一步地,所述pH调节剂为氢氧化钠、精氨酸、氨丁三醇中的一种。
作为其中的一个实施例,优选地,所述pH调节剂为氢氧化钠。
进一步地,所述防腐剂为对羟基苯乙酮和/或己二醇。
实施例1
制备用于光电术后屏障修护的面膜,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,按质量份:
A相:水、1份甘油聚醚-26、1份甘油、1份甜菜碱、0.3份卡波姆;
B相:1.4份脂质补充剂(由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成)、0.5份三(月桂醇聚醚-4)磷酸酯;
C相:氢氧化钠(用以调节系统pH值为6)、0.25份对羟基苯乙酮、0.25份己二醇、1.5份烟酰胺;
D相:4份甘油葡糖苷、0.5份乳酸杆菌/豆浆发酵产物滤液、0.3份泛醇、0.3份香叶天竺葵花/叶/茎提取物、0.3份金黄洋甘菊提取物、0.3份马齿苋花/叶/茎提取物、0.3份库拉索芦荟叶提取物、1.5份琥珀酸二乙氧基乙酯。
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异时,得到用于光电术后屏障修护的面膜。
实施例2
制备用于光电术后屏障修护的面膜,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,按质量份:
A相:水、0.05份丁二醇、0.05份1,2-戊二醇、0.5份丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物;
B相:0.1份脂质补充剂(由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成)、0.1份三(月桂醇聚醚-4)磷酸酯;
C相:氢氧化钠(用以调节系统pH值为5.28)、0.5份对羟基苯乙酮、0.1份烟酰胺;
D相:2份木糖醇葡糖苷、1份乳酸杆菌/绿豆籽提取物/谷氨酸钠发酵产物滤液、1份泛醇、1份香叶天竺葵花/叶/茎提取物、1份金黄洋甘菊提取物、0.1份辛酸/癸酸甘油三酯;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异时,得到用于光电术后屏障修护的面膜。
实施例3
制备用于光电术后屏障修护的面膜,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,按质量份:
A相:水、4份甘油、4份甘油聚醚-26、0.01份丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物;
B相:3份脂质补充剂(由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成)、1份三(月桂醇聚醚-4)磷酸酯;
C相:氢氧化钠(用以调节系统pH值为6.28)、0.05份对羟基苯乙酮、0.05份己二醇、3份烟酰胺;
D相:2份脱水木糖醇、0.5份乳酸杆菌/北美圣草发酵产物提取物、0.2份马齿苋花/叶/茎提取物、0.2份库拉索芦荟叶提取物、3份角鲨烷;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异时,得到用于光电术后屏障修护的面膜。
实施例4
制备用于光电术后屏障修护的面膜,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,按质量份:
A相:水、1份1,2-己二醇、1份甲基葡糖醇聚醚-10、0.05份卡波姆;
B相:1份脂质补充剂(由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成)、0.5份三(月桂醇聚醚-4)磷酸酯;
C相:氢氧化钠(用以调节系统pH值为5.28-6.28)、0.5份己二醇、脂质甲基葡糖醇聚醚-10、2份烟酰胺;
D相:2份木糖醇、0.1份乳酸杆菌/豆浆发酵产物滤液、0.1份泛醇、0.1份香叶天竺葵花/叶/茎提取物、0.1份金黄洋甘菊提取物、2份氢化聚异丁烯;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异时,得到用于光电术后屏障修护的面膜。
实施例5
制备用于光电术后屏障修护的面膜,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,按质量份:
A相:水、8份透明质酸钠、0.3份卡波姆;
B相:2份脂质补充剂(由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成)、0.8份三(月桂醇聚醚-4)磷酸酯;
C相:氨丁三醇(用以调节系统pH值为5.28-6.28)、1份对羟基苯乙酮、1份烟酰胺;
D相:2份甘油葡糖苷、0.3份乳酸杆菌/豆浆发酵产物滤液、0.1份泛醇、0.1份香叶天竺葵花/叶/茎提取物、0.1份金黄洋甘菊提取物、0.1份马齿苋花/叶/茎提取物和库拉索芦荟叶提取物、0.5份琥珀酸二乙氧基乙酯、0.5份辛酸/癸酸甘油三酯;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异时,得到用于光电术后屏障修护的面膜。
实施例6
制备用于光电术后屏障修护的面膜,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,按质量份:
A相:水、3份甘油、2份丁二醇、0.1份卡波姆;
B相:0.5份脂质补充剂(由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成)、0.6份三(月桂醇聚醚-4)磷酸酯;
C相:精氨酸(用以调节系统pH值为5.28-6.28)、0.1份对羟基苯乙酮、0.1份己二醇、0.5份烟酰胺;
D相:2份甘油葡糖苷、2.5份乳酸杆菌/豆浆发酵产物滤液、0.2份泛醇、0.2份香叶天竺葵花/叶/茎提取物、0.2份金黄洋甘菊提取物、0.2份马齿苋花/叶/茎提取物、0.5份库拉索芦荟叶提取物、0.5份辛酸/癸酸甘油三酯、0.5份角鲨烷、0.5份氢化聚异丁烯;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异时,得到用于光电术后屏障修护的面膜。
将本发明实施例所得面膜经志愿者对屏障修复效果进行测试,结果显示,本发明产品能够明显改善光电术后皮肤的干燥、提高皮肤角质层水分、并保湿持久。
本发明提供的面膜能够有效修护激光类项目对皮肤产生的副作用及对术后并发症的修复,能够有效补充生理脂质,修复皮肤屏障,恢复水通道蛋白的正常功能;并能够明显改善光电术后皮肤的干燥、提高皮肤角质层水分、并保湿持久。
当然,上述说明并非是对本发明的限制,本发明也并不仅限于上述举例,本技术领域的技术人员在本发明的实质范围内所做出的变化、改型、添加或替换,也应属于本发明的保护范围。
Claims (10)
1.一种用于光电术后屏障修护的面膜,其特征在于,按质量百分比,包括:
水分补充剂0.1-8%、润肤剂0.1-3%、乳化剂0.1-1%、水通道蛋白激活剂2%、脂质补充剂0.1-3%、敏感修护剂0.1-3%、脂质再生激活剂0.1-3%、益生菌激活剂0.1-1%、增稠剂0.01-0.5%、pH调节剂0.01-0.1%,防腐剂0.1-1%,余量为水,以上组分的质量百分比之和为100%。
2.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述脂质补充剂由神经酰胺NP、胆固醇和向日葵籽油按质量2:4:1配比构成。
3.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述水通道蛋白激活剂为甘油葡糖苷、木糖醇葡糖苷、脱水木糖醇、木糖醇中的一种。
4.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述水分补充剂为甘油、丁二醇、1,2-戊二醇、1,2-己二醇、甘油聚醚-26、甜菜碱、甲基葡糖醇聚醚-10、透明质酸钠中的一种或多种。
5.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述润肤剂为琥珀酸二乙氧基乙酯、辛酸/癸酸甘油三酯、角鲨烷、氢化聚异丁烯中的一种或多种。
6.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述乳化剂为三(月桂醇聚醚-4)磷酸酯。
7.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述敏感修护剂为泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物、库拉索芦荟叶提取物中的一种或多种。
8.根据权利要求1所述的一种用于光电术后屏障修护的面膜,其特征在于,所述益生菌激活剂为乳酸杆菌/豆浆发酵产物滤液、乳酸杆菌/绿豆籽提取物/谷氨酸钠发酵产物滤液、乳酸杆菌/北美圣草发酵产物提取物中的一种。
9.根据权利要求1-8任意一项所述的一种用于光电术后屏障修护的面膜的制备方法,其特征在于,包括以下步骤:
(1)将A相加入洁净的乳化锅中,开中速搅拌、开加热升温至(85℃±1)℃,保温15min,开中速均质3min至均匀,乳化锅保持在(85±1)℃,抽真空,开低速保温搅拌10-15min;
(2)将B相加入洁净的油锅中,开加热升温至(85℃±1)℃;
(3)将B相加入A相开中速均质3min至均匀,抽真空,降温;
(4)45℃加入C、D、E相搅拌5-8min至均匀;
(5)38℃取料检验合格后,用二层400目滤布过滤出料;
其中,
A相:水、水分补充剂、增稠剂;
B相:脂质补充剂、乳化剂;
C相:pH调节剂、防腐剂、脂质再生激活剂;
D相:水通道蛋白激活剂、益生菌激活剂、敏感修护剂、润肤剂;
观察上述步骤做完后的料体外观为轻微朦胧的流动黏稠液体,于40±1℃保持24h后取样,恢复室温后无油水分离现象,且于-8±2℃保持24h,恢复室温后与试验前无明显形状差异,即得到本发明的面膜。
10.根据权利要求9所述的一种用于光电术后屏障修护的面膜的制备方法,其特征在于,其中,
A相:水、甘油聚醚-26、甘油、甜菜碱、卡波姆;
B相:向日葵籽油、神经酰胺NP、胆固醇、三(月桂醇聚醚-4)磷酸酯;
C相:水、氢氧化钠、对羟基苯乙酮、己二醇、烟酰胺;
D相:甘油葡糖苷、乳酸杆菌/豆浆发酵产物滤液、泛醇、香叶天竺葵花/叶/茎提取物、金黄洋甘菊提取物、马齿苋花/叶/茎提取物、库拉索芦荟叶提取物、琥珀酸二乙氧基乙酯。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111575163.9A CN114366708A (zh) | 2021-12-21 | 2021-12-21 | 一种用于光电术后屏障修护的面膜及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111575163.9A CN114366708A (zh) | 2021-12-21 | 2021-12-21 | 一种用于光电术后屏障修护的面膜及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114366708A true CN114366708A (zh) | 2022-04-19 |
Family
ID=81141009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111575163.9A Pending CN114366708A (zh) | 2021-12-21 | 2021-12-21 | 一种用于光电术后屏障修护的面膜及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114366708A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108836905A (zh) * | 2018-07-11 | 2018-11-20 | 佛山市奥姿美生物科技有限公司 | 刺激细胞水通道蛋白生成的保湿修护组合物 |
CN112370364A (zh) * | 2020-11-24 | 2021-02-19 | 西安润玉医疗科技有限公司 | 一种皮肤屏障修复仿生组合物及其制备方法 |
CN114681385A (zh) * | 2022-03-15 | 2022-07-01 | 北京至乐界生物科技有限公司 | 一种舒缓修复组合物及制备方法和在敏感肌修护的应用 |
-
2021
- 2021-12-21 CN CN202111575163.9A patent/CN114366708A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108836905A (zh) * | 2018-07-11 | 2018-11-20 | 佛山市奥姿美生物科技有限公司 | 刺激细胞水通道蛋白生成的保湿修护组合物 |
CN112370364A (zh) * | 2020-11-24 | 2021-02-19 | 西安润玉医疗科技有限公司 | 一种皮肤屏障修复仿生组合物及其制备方法 |
CN114681385A (zh) * | 2022-03-15 | 2022-07-01 | 北京至乐界生物科技有限公司 | 一种舒缓修复组合物及制备方法和在敏感肌修护的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999045900A1 (fr) | Agents de normalisation pour la peau | |
CN111166683A (zh) | 一种富勒烯抗衰抗氧化美容护肤化妆品及其制备方法 | |
CN104856892A (zh) | 一种富含生长因子的化妆品或护肤品制剂及其制备方法 | |
KR101810231B1 (ko) | 프로폴리스 미세침 분말을 함유하는 화장료 조성물 | |
CN111053709A (zh) | 一种山茶籽油面贴膜用乳液、面贴膜及其制备方法 | |
CN110638707A (zh) | 一种眼部护理霜及其制备方法 | |
CN110731923A (zh) | 增强的保湿化妆品组合物 | |
CN110974767A (zh) | 用于皮肤屏障再生修复的组合物及其应用 | |
CN110960458A (zh) | 一种保湿精华乳液及其制备方法 | |
CN112137951A (zh) | 一种强韧发丝修复头皮屏障的无硅油透明氨基酸洗发水及其制备方法 | |
CN115105453A (zh) | 一种具有抗菌、消炎和修复功能的护肤品及其制备方法 | |
CN111920730A (zh) | 一种修复保湿霜及其制备方法 | |
CN106727122B (zh) | 一种淡化妊娠纹护肤乳液及其制备方法 | |
CN114667129B (zh) | 用于护理角蛋白材料的套装 | |
CN107468610A (zh) | 一种米糠壳的提取产物及其在面部护理的应用 | |
CN117643564A (zh) | 一种中药美白精华乳剂凝胶及其制备方法 | |
CN113384482A (zh) | 一种保湿嫩肤精华露及其制备方法 | |
KR101896563B1 (ko) | 제주광나무 추출물을 함유하는 보습용 화장료 조성물 | |
CN114053181A (zh) | 一种抗皱组合物及其在护肤品中的应用 | |
CN111419770A (zh) | 保湿修复型温感唤醒面膜及其制备方法 | |
CN114366708A (zh) | 一种用于光电术后屏障修护的面膜及其制备方法 | |
CN110876686A (zh) | 一种修复组合物及其制备方法 | |
CN111012699A (zh) | 一种含褐藻糖海带提取物的抗氧化控油乳液 | |
JPH08268859A (ja) | シワ予防・改善化粧料 | |
JP3522609B2 (ja) | ヒアルロン酸産生促進剤、及びこれを含有して成る皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220419 |
|
RJ01 | Rejection of invention patent application after publication |